CAAS MR 4D Flow
System, Image Processing, Radiological. 510(k) K162376, from Pie Medical Imaging BV (Maastricht, NL). Product code LLZ, class 2.
As of Nov 19, 2026, K162376 is an FDA 510(k) held by Pie Medical Imaging BV, substantially equivalent on Dec 8, 2016 after 106 days, with no recalls tied to it in FDA's recall database.
- Review time: 106 days
- Recalls: 0
- Cited as a predicate by: 2 devices
CAAS MR 4D Flow enables the analysis of blood flow in the heart and large vessels based on multi-slice, multi-phase and velocity encoded MR images by providing the following functionality: • Segmentation of cardiovascular structures; • Visualization of blood flow velocity and directions; • Calculation of quantitative cardiovascular results.
- Heartscan SoftwareK133937 · Morpheus Imaging, Inc. · Mar 3, 2014
- Synapse 3D Blood Flow AnalysisK191544 · Fujifilm Corporation · Oct 18, 2019
- CAAS MR SolutionsK181825 · Pie Medical Imaging BV · Dec 4, 2018
- 3D Anatomical ModelK262132 · The Jacobs Institute · Nov 5, 2026
- LiLi DICOM Viewer (LiLi )K260454 · Elevate Imaging, Inc. · Nov 4, 2026
- Vitrea Advanced Visualization, Version 7.16K263648 · Canon Medical Informatics, Inc. · Oct 29, 2026
- MIM – KineticIDK261763 · Mim Software, Inc. · Oct 26, 2026
- PV-iCurve ProK261531 · Perception Vision Medical Technology Co., Ltd. · Oct 21, 2026
- Eden PACSK261788 · Higia., Inc. d/b/a Eden · Oct 21, 2026
- Syngo Carbon Space (VA4)K263048 · Siemens Healthineers AG · Sep 29, 2026
- Syneris PACS v.1.0.1.0K261874 · Syneris · Sep 23, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 24, 2016
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files